Ju Mila H, Chung Jeanette W, Kinnier Christine V, Bentrem David J, Mahvi David M, Ko Clifford Y, Bilimoria Karl Y
*Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL †Surgical Outcomes and Quality Improvement Center, Department of Surgery, Northwestern University, Chicago, IL ‡Department of Surgery, University of California, Los Angeles (UCLA), and VA Greater Los Angeles Healthcare System, Los Angeles, CA.
Ann Surg. 2014 Sep;260(3):558-64; discussion 564-6. doi: 10.1097/SLA.0000000000000897.
The objective was to assess the presence and extent of venous thromboembolic (VTE) surveillance bias using high-quality clinical data.
Hospital VTE rates are publicly reported and used in pay-for-performance programs. Prior work suggested surveillance bias: hospitals that look more for VTE with imaging studies find more VTE, thereby incorrectly seem to have worse performance. However, these results have been questioned as the risk adjustment and VTE measurement relied on administrative data.
Data (2009-2010) from 208 hospitals were available for analysis. Hospitals were divided into quartiles according to VTE imaging use rates (Medicare claims). Observed and risk-adjusted postoperative VTE event rates (regression models using American College of Surgeons National Surgical Quality Improvement Project data) were examined across VTE imaging use rate quartiles. Multivariable linear regression models were developed to assess the impact of hospital characteristics (American Hospital Association) and hospital imaging use rates on VTE event rates.
The mean risk-adjusted VTE event rates at 30 days after surgery increased across VTE imaging use rate quartiles: 1.13% in the lowest quartile to 1.92% in the highest quartile (P < 0.001). This statistically significant trend remained when examining only the inpatient period. Hospital VTE imaging use rate was the dominant driver of hospital VTE event rates (P < 0.001), as no other hospital characteristics had significant associations.
Even when examined with clinically ascertained outcomes and detailed risk adjustment, VTE rates reflect hospital imaging use and perhaps signify vigilant, high-quality care. The VTE outcome measure may not be an accurate quality indicator and should likely not be used in public reporting or pay-for-performance programs.
利用高质量临床数据评估静脉血栓栓塞症(VTE)监测偏倚的存在情况及程度。
医院VTE发生率会公开报告并用于绩效付费项目。先前的研究提示存在监测偏倚:更多使用影像学检查来筛查VTE的医院发现的VTE更多,因此表面上绩效似乎更差,但这种情况是不正确的。然而,由于风险调整和VTE测量依赖行政数据,这些结果受到了质疑。
可获取208家医院2009 - 2010年的数据用于分析。根据VTE影像学使用率(医疗保险理赔数据)将医院分为四分位数组。在不同VTE影像学使用率四分位数组中,检查观察到的和经风险调整后的术后VTE事件发生率(使用美国外科医师学会国家外科质量改进项目数据的回归模型)。建立多变量线性回归模型,以评估医院特征(美国医院协会数据)和医院影像学使用率对VTE事件发生率的影响。
术后30天经风险调整后的VTE事件平均发生率随VTE影像学使用率四分位数组升高而增加:最低四分位数组为1.13%,最高四分位数组为1.92%(P < 0.001)。仅检查住院期间时,这种具有统计学意义的趋势依然存在。医院VTE影像学使用率是医院VTE事件发生率的主要驱动因素(P < 0.001),因为没有其他医院特征与之有显著关联。
即使采用临床确定的结果和详细的风险调整进行检查,VTE发生率仍反映医院的影像学使用情况,可能意味着警惕、高质量的医疗。VTE结果指标可能不是一个准确的质量指标,不太应用于公开报告或绩效付费项目。